A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines
Description
CONCLUSION: Although a homogenous booster dose following two doses of the inactivated COVID-19 vaccine among PLWH could elicit higher nAb titers, reduce antibody decay, and maintain T cell responses even 6 months after vaccination, the overall
